For example, GLP-1 agonists have been linked to gastrointestinal issues, pancreatitis, increased risk of depression and suicide, nephrolithiasis or kidney disease, and, in a few cases, acute kidney disease downstream of dehydration from gastrointestinal issues [113,114]. Here, GLP1R is linked to nephrolithiasis.